You can buy or sell Allakos and other stocks, options, ETFs, and crypto commission-free!
Allakos Inc. Common Stock, also called Allakos, is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. Read More The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in Redwood, CA.
52 Week High
52 Week Low
-$0.31 per share
-$0.35 per share